Revolutionizing Cancer Treatment with T Cell Therapy скачать в хорошем качестве

Revolutionizing Cancer Treatment with T Cell Therapy

Most adoptive T cell therapies collapse against solid tumors, but our recent Cancer Cell study (Cole et al.) reveals a surprising solution: T helper 17 (Th17) cells working hand-in-hand with B cells. These unconventional partners don’t just attack tumors; they build lasting immunity by fueling germinal center reactions, antibody class switching, and durable T cell memory. In this talk, I’ll share how Th17–B cell cooperation rewrites the rules of tumor immunology and how we’re translating these insights into next-generation TIL products for patients who fail checkpoint blockade. If you want a first look at how re-programming “helper” cells could finally crack the solid tumor problem, this is the session to catch.